Clinical Trial Update: Identification of Carnitine-Responsive Cardiomyopathy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining carnitine-responsive cardiomyopathy in patients with carnitine deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy
• Carnitine Deficiency

Snippet

Sponsor: University Health Network, Toronto | Conditions: Carnitine Deficiency | Phase 4 | Status: UNKNOWN